Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ark Genomic Revolution ETF (NY: ARKG )

28.90 +0.90 (+3.21%)
Streaming Delayed Price Updated: 3:38 PM EDT, Mar 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ark Genomic Revolution ETF

< Previous 1 2 3 4 Next >
10 Best Stocks to Buy in March 2023
These diversified growth stocks could add rocket fuel to your long-term investment portfolio. 
Via The Motley Fool
Cathie Wood Makes Biggest Coinbase Purchase Of Year After Earnings Beat
Cathie Wood and her ARK Invest firm bought $13 million in COIN stock as they bulk up holdings following Coinbase earnings. 
Via Investor's Business Daily
3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street
These stocks are risky. But they just might deliver huge gains if analysts are right. 
Via The Motley Fool
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy? 
Via Talk Markets
Cathie Wood Trims Robinhood Stake As Stock Gains 28% In January — Also Offloads Shares In This Biotech Company
Cathie Wood-led ARK Investment Management sold 85,337 shares of financial services company Robinhood Markets Inc (NASDAQ: HOOD) at 
Via Benzinga
Why Teladoc Stock Popped 5% Today
Cathie Wood keeps buying shares of the telemedicine company. Should you? 
Via The Motley Fool
Healthcare Sector Is Lagging As We Enter 2022 Earnings Season
The healthcare sector is perceived as defensive but in 2023 there is more investor appetite for risk based on the QQQ comeback and the XBI strength. 
Via Talk Markets
Don't Call It A Comeback: Cathie Wood Is Beating The S&P 500 In Early 2023
The competition could be paying the price in 2023 if Ark Invest can keep up with its early performance at the start of the year. 
Via Benzinga
J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps
Large cap biopharmas that outperformed in 2022 were generally weak last week from profit-taking and portfolio rebalancing. 
Via Talk Markets
Cathie Wood Makes This Molecular Diagnostics Company Top Holding Of Ark Invest's Flagship Fund, Catapulting Past Zoom, Tesla
Shares of Exact Sciences, Inc. (NASDAQ: EXAS) have been on a tear, having gained over 27% in two sessions this week. 
Via Benzinga
Cathie Wood Gets Elon Musk's Attention Over Gene-Editing Therapy Potential: 'Investors Chased The Dream Then. Now, They're Running Away'
Cathie Wood of ARK Investment Management believes U.S. equity markets are the polar opposite of what they were in the 90s when investors chased their dreams. 
Via Benzinga
War, Inflation, Fed Hawkishness, Elon Musk's Twitter Buy: How These Factors Weighed On Cathie Wood's Top Holdings In 2022
In 2022, financial markets witnessed one of the worst routs in history, dragged by the war in Ukraine, rising inflation and subsequent hawkish policies deployed by central banks. 
Via Benzinga
Precious Metals Outperformed Stocks And Bonds In 2022
The power of silver's rebound has surprised many, even its most ardent supporters. 
Via Talk Markets
2 Cathie Wood Stocks to Buy and Hold Through 2023 and Beyond
These two biotechs are flying high right now. 
Via The Motley Fool
'Study The Mindset Of Stonk Hodlers': This Fund Manager Rips Cathie Wood's Investment Strategy
ETF fund manager Cathie Wood is known for investing in growth stocks and what she has labeled as “innovation.” A take by the fund manager drew criticism from a hedge fund manager. 
Via Benzinga
Cathie Wood Adds $7M Of This Clinical-Stage Biotech, Trims Stake In CVS-Target Signify Health
Cathie Wood-led ARK Investment Management bought over 330,000 shares of clinical-stage biotechnology company Verve Therapeutics Inc (NASDAQ: VERV) at an estimated valuation of over $6.9 million, based... 
Via Benzinga
Getting Ready For The Coming Stock Market Elevator Drop
In this video Kirk Spano updates trends in Global ETFs and discusses why he thinks stocks are headed down in a big way. 
Via Talk Markets
This Congressman Just Purchased 2 Stocks Which Consistently Increase Dividends
Congressman Dwight Evans (D-PA) has represented Pennsylvania's Third Congressional District since 2019, and has made over 70 trades in the past three years. His top two traded investments are Intel... 
Via Benzinga
Cathie Wood Has Bet Big On These 10 Stocks; Here's How They're Performing
Here's how Ark Invest's top holdings have performed in 2022. 
Via Investor's Business Daily
Cathie Wood Is Selling This High-Flying Stock. Here's Why You Should Buy It Instead
The ARK Invest founder might regret trimming her position in this biotech stock. 
Via The Motley Fool
Cathie Wood Increases Stake In 4 Stocks By Over 1,000% - Plus 4 New Holdings For Ark
Cathie Wood’s ARK Innovation ETF (ARCA: ARKK) is down roughly 63% year-to-date, compared to the NASDAQ which is down at least 29% year-to-date and the S&P 500 down over 16% year-to-date. 
Via Benzinga
Cathie Wood Teams Up With This Investment Bank To Offer Ark Invest's ETFs In Canada
Cathie Wood’s Ark Invest, this week, announced a deal with Canadian investment manager BMO Capital Markets. 
Via Benzinga
Cathie Wood Loads Up Over $6.7M In Adobe Stock As It Tumbles 27% In A Month — Also Adds Stake In This Biopharma Company
Cathie Wood-led ARK Investment Management bought over 23,000 shares of software maker Adobe Inc (NASDAQ: ADBE) through the 
Via Benzinga
ARK Invest Short Sellers Have $2.3B In Profits So Far In 2022
After a horrible 2021 for Cathie Wood, the ARK Innovation ETF (NYSE: ARKK) is down another 59.1% in 2022. High-growth tech stocks have taken a beating as interest rates have spiked, sending ARK Invest... 
Via Benzinga
Cathie Wood Sells $2.8M In Healthcare Stock Buoyed By Amazon-Linked Rumors
Cathie Wood-led Ark Investment Management on Wednesday sold 96,746 shares of Signify Health Inc. (NYSE: SGFY), estimated to be valued at around $2.8 million. 
Via Benzinga
Cathie Wood Splurges $22M To Hike Stake In This Chipmaker Stock Worrying Jim Cramer
Cathie Wood’s Ark Investment Management on Monday hiked its stake in chip manufacturer Nvidia Corporation (NASDAQ: NVDA) via the ARK Genomic Revolution ETF (NYSE: ARKG). 
Via Benzinga
Cathie Wood Loads Up $23M Worth Of Shares In This Gene-Editing Company As Stock Falls Over 10% In A Month
Cathie Wood-led Ark Investment Management on Friday raised its stake in clinical stage genetics medicine company Verve Therapeutics Inc (NASDAQ: VERV) via two of its exchange-traded funds. 
Via Benzinga
Cathie Wood Buys Nearly $7M In This Sapped Bitcoin-Linked Stock — Also Picks Up Shares In CareDx
Cathie Wood-led Ark Investment Management has bought over 100,000 shares of Jack Dorsey’s Block Inc (NYSE: SQ), valued at over $6.9 million based on Wednesday’s closing price. 
Via Benzinga
Benzinga Before The Bell: Tesla Sues Louisiana Automobile Dealers Association, Will iPhone 14 Feature Satellite Connectivity?, Netflix Denies $7 To $9 Ad-Supported Plan And Other Top Financial Stories Tuesday, August 30
Reuters Taiwan’s China Airlines Orders 16 Boeing 787s 
Via Benzinga
Cathie Wood Loads Up $3M In This Precision Medicine Firm's Shares Despite Bleak Q2 Results
Cathie Wood-led Ark Investment Management loaded up on 153,917 shares of precision medicine company CareDx Inc (NASDAQ: CDNA), via the ARK Genomic Revolution ETF (NYSE: ARKG< 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.